Your session is about to expire
← Back to Search
Hydrocolloid vs Petrolatum Dressings for Surgical Scars
N/A
Recruiting
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients underwent conventional excision or Mohs micrographic surgery for primary cutaneous cancer or other cutaneous condition that required surgical intervention
Adult > 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days, 30 days, 90 days
Awards & highlights
Study Summary
This trial will compare two dressings to see which one gives better cosmetic results for surgical scars. Patients and surgeons will evaluate the results.
Who is the study for?
This trial is for adults over 18 who have linear scars from skin cancer or similar conditions requiring surgery. It's not for those with allergies to adhesives, past hydrocolloid dressing use, flap or graft wounds, topical chemotherapy near the site within 3 months post-surgery, or scars on acral/hairy areas.Check my eligibility
What is being tested?
The study compares two types of dressings on surgical scars: a hydrocolloid dressing left in place for a week versus daily-applied petrolatum jelly and bandages. The scar appearance will be assessed by patients and surgeons after 7, 30, and 90 days.See study design
What are the potential side effects?
Potential side effects may include skin irritation or allergic reactions due to the adhesive in the hydrocolloid dressing. Regular petrolatum jelly application might cause discomfort during re-application.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had surgery for skin cancer or a skin condition needing surgery.
Select...
I am older than 18 years.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 7 days, 30 days, 90 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days, 30 days, 90 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Cosmetic outcome
Secondary outcome measures
Complication rate
Side effects data
From 2010 Phase 4 trial • 39 Patients • NCT0109346915%
upper respiratory infection
100%
80%
60%
40%
20%
0%
Study treatment Arm
Atopiclair Nonsteroidal Cream
Aquaphor Healing Ointment
EpiCream Skin Barrier Emulsion
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: hydrocolloid dressing armExperimental Treatment1 Intervention
After informed consent and closing the wound with the sutures, the scar will be covered by a hydrocolloid dressing, which will be left in place for 7 days (Experimental)
Group II: Petrolatum jelly dressing armActive Control1 Intervention
and the other group of patients (control), after closing the wound with the sutures, the scar will be covered with petrolatum jelly during this time period, which has to be re-applied daily.
Find a Location
Who is running the clinical trial?
Indiana UniversityLead Sponsor
980 Previous Clinical Trials
981,726 Total Patients Enrolled
3 Trials studying Wound Healing
267 Patients Enrolled for Wound Healing
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this experiment accepting new participants currently?
"According to clinicaltrials.gov, the trial is presently enrolling participants since it was posted on October 17th 2022 and last revised November 9th 2022."
Answered by AI
What is the current enrollment size for this clinical trial?
"Confirmative. According to the information hosted on clinicaltrials.gov, this medical trial was initially posted on October 17th 2022 and is actively recruiting patients. 75 candidates need to be recruited from a single location for successful completion of the study."
Answered by AI
Share this study with friends
Copy Link
Messenger